These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24975911)

  • 1. Comorbidities and differential diagnosis in heart failure with preserved ejection fraction.
    Campbell RT; McMurray JJ
    Heart Fail Clin; 2014 Jul; 10(3):481-501. PubMed ID: 24975911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in patients with heart failure with preserved ejection fraction.
    Poppe KK; Doughty RN
    Heart Fail Clin; 2014 Jul; 10(3):503-10. PubMed ID: 24975912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and pathophysiology of heart failure with preserved ejection fraction.
    Kovács Á; Papp Z; Nagy L
    Heart Fail Clin; 2014 Jul; 10(3):389-98. PubMed ID: 24975903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heart failure with preserved ejection fraction: Diastolic heart failure].
    Rutten FH; Cramer MJ; Paulus WJ
    Ned Tijdschr Geneeskd; 2012; 156(45):A5315. PubMed ID: 23134752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic impact of heart failure with preserved versus reduced ejection fraction in patients with mild symptoms].
    Jung P; Huber T; Müller M; König A; Krötz F; Sohn HY
    Dtsch Med Wochenschr; 2012 Apr; 137(14):706-10. PubMed ID: 22454198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does treatment improve prognosis of heart failure with preserved ejection fraction?].
    Schläpfer-Pessina A; Carballo S; Perrier A; Garin N
    Rev Med Suisse; 2015 Jan; 11(458):199-205. PubMed ID: 25831613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides in heart failure with preserved ejection fraction.
    Richards AM; Januzzi JL; Troughton RW
    Heart Fail Clin; 2014 Jul; 10(3):453-70. PubMed ID: 24975909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study).
    Magaña-Serrano JA; Almahmeed W; Gomez E; Al-Shamiri M; Adgar D; Sosner P; Herpin D;
    Am J Cardiol; 2011 Nov; 108(9):1289-96. PubMed ID: 22000627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction.
    Tromp J; van der Pol A; Klip IT; de Boer RA; Jaarsma T; van Gilst WH; Voors AA; van Veldhuisen DJ; van der Meer P
    Circ Heart Fail; 2014 May; 7(3):457-62. PubMed ID: 24647119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
    Streng KW; Nauta JF; Hillege HL; Anker SD; Cleland JG; Dickstein K; Filippatos G; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Damman K; van der Meer P; Voors AA
    Int J Cardiol; 2018 Nov; 271():132-139. PubMed ID: 30482453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.
    Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
    Eur Heart J; 2012 Jul; 33(14):1750-7. PubMed ID: 21821849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure.
    Vivo RP; Krim SR; Krim NR; Zhao X; Hernandez AF; Peterson ED; Piña IL; Bhatt DL; Schwamm LH; Fonarow GC
    Circ Heart Fail; 2012 Mar; 5(2):167-75. PubMed ID: 22414939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction.
    Badheka AO; Rathod A; Kizilbash MA; Bhardwaj A; Ali O; Afonso L; Jacob S
    Am J Cardiol; 2011 Nov; 108(9):1283-8. PubMed ID: 21855829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with recovered ejection fraction: a distinct clinical entity.
    Punnoose LR; Givertz MM; Lewis EF; Pratibhu P; Stevenson LW; Desai AS
    J Card Fail; 2011 Jul; 17(7):527-32. PubMed ID: 21703523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent non-cardiac comorbidities in patients with chronic heart failure.
    Dahlström U
    Eur J Heart Fail; 2005 Mar; 7(3):309-16. PubMed ID: 15718170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction.
    van Diepen S; Chen AY; Wang TY; Alexander KP; Ezekowitz JA; Peterson ED; Roe MT
    Am Heart J; 2014 Feb; 167(2):267-273.e1. PubMed ID: 24439989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction.
    Chamberlain AM; Boyd CM; Manemann SM; Dunlay SM; Gerber Y; Killian JM; Weston SA; Roger VL
    Am J Med; 2020 Jun; 133(6):e237-e248. PubMed ID: 31747542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
    Patel PA; Liang L; Khazanie P; Hammill BG; Fonarow GC; Yancy CW; Bhatt DL; Curtis LH; Hernandez AF
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.